Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q2 2023 Earnings Call Transcript August 8, 2023
Syros Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-1.3 EPS, expectations were $1.11.
Operator: Good morning, and welcome to Syros Pharmaceuticals’ Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in listen only mode. This call is being webcast live on the Investors and Media section of Syros’ website at www.syros.com. Please be advised...
